Leaders in Pharmaceutical Business Intelligence (LPBI) Group

My speciality is bone biology, nitric oxide and clinical context of research. I did my PhD on mechanosensing and chemical signalling in single osteocytes’ . Major achievements of the project were quantification of nitric oxide at single cell level, online monitoring of nitric oxide in live single cells, determination of  mechanosensitive part of single osteocyte, determination of the capacity of single osteocyte to sense external mechanical loads and transmit this information via signalling to the surrounding effector cells. Research areas of my interest are broadly: osteocytes, nitric oxide in physiology and therapy, mechanosensing in cells, bioengineering, bone physiology, mechanotransduction by cells, microscopy, confocal microscopy,  imaging techniques, interdisciplinary approach (converging biology, clinics, physics, engineering and bioinformatics). My principle work experience includes a couple of years of post doc, worked with a biotech company, Clinical work in India and Teaching at a University in England.

Publications: https://scholar.google.co.uk/citations?user=_Sv0TMUAAAAJ&hl=en&oi=sra

 Mechanosensation and Mechanotransduction: Our Connection to the

Outside World February 6, 2013

 Osteocytes: A Special Issue in Bone January 4, 2013

 Reduction in Inappropriate Therapy and Mortality through ICD Programming

November 22, 2012

 Overview of New Strategy for Treatment of T2DM: SGLT2 Inhibiting Oral

Antidiabetic Agents October 28, 2012

 Nitric Oxide and Immune Responses: Part 2 October 18, 2012

 Nitric Oxide and Immune Responses: Part 1 September 30, 2012

 Targeted delivery of therapeutics to bone and connective tissues: current

status and challenges- Part II

 Targeted delivery of therapeutics to bone and connective tissues: current

status and challenges- Part I September 18, 2012

 Discovery of nitric oxide and its role in vascular biology September 11, 2012

 Nitric Oxide: role in Cardiovascular health and disease August 22, 2012

 Nitric Oxide Signalling Pathways August 10, 2012

 Nitric Oxide: Chemistry and function August 6, 2012

 Selective glucocorticoid receptor modulation maintains bone mineral density

in mice August 6, 2012

 Loss of wnt/β‐catenin signaling causes cell fate shift of preosteoblasts from

osteoblasts to adipocytes